• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病相关肝细胞癌的流行病学及其影响

Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.

作者信息

Wong Sui-Weng, Ting Yi-Wen, Chan Wah-Kheong

机构信息

Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia.

出版信息

JGH Open. 2018 Jul 17;2(5):235-241. doi: 10.1002/jgh3.12070. eCollection 2018 Oct.

DOI:10.1002/jgh3.12070
PMID:30483595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6206984/
Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading cause of cancer-related mortality worldwide. Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver pathology that is characterized by the excessive accumulation of fat in the liver attributable to overnutrition and is strongly associated with the metabolic syndrome. Non-alcoholic steatohepatitis is the more severe form of NAFLD that is defined histologically by the presence of lobular inflammation and hepatocyte ballooning. Non-alcoholic steatohepatitis patients have a greater tendency to develop advanced liver fibrosis, cirrhosis, and HCC. This review focuses on the epidemiology of NAFLD-related HCC and its implications. NAFLD has been estimated to contribute to 10-12% of HCC cases in Western populations and 1-6% of HCC cases in Asian populations. NAFLD-related HCC is expected to increase in Asian populations, in line with the increased prevalence of NALFD similar to that of Western populations in recent years. The increasing burden of NAFLD-related HCC over time has been demonstrated in studies from both Western and Asian populations. Certain factors such as ethnicity, obesity, and diabetes mellitus appear to have an incremental effect on the risk of developing HCC among NAFLD patients. The difficulty in identifying NAFLD patients with cirrhosis and the possibility of HCC developing in noncirrhotic NAFLD patients are challenges that need to be addressed. Further understanding of these gaps may contribute to better surveillance strategies for the early detection of HCC in NAFLD patients to reduce the mortality and improve the survival of these patients.

摘要

肝细胞癌(HCC)是全球第五大常见癌症,也是癌症相关死亡的第二大主要原因。非酒精性脂肪性肝病(NAFLD)涵盖一系列肝脏病理状态,其特征是由于营养过剩导致肝脏脂肪过度蓄积,且与代谢综合征密切相关。非酒精性脂肪性肝炎是NAFLD更严重的形式,在组织学上由小叶炎症和肝细胞气球样变来定义。非酒精性脂肪性肝炎患者发生晚期肝纤维化、肝硬化和HCC的倾向更大。本综述重点关注NAFLD相关HCC的流行病学及其影响。据估计,在西方人群中,NAFLD导致10% - 12%的HCC病例,在亚洲人群中导致1% - 6%的HCC病例。随着近年来NAFLD患病率的增加,与西方人群类似,预计亚洲人群中与NAFLD相关的HCC也会增加。西方和亚洲人群的研究均表明,随着时间推移,与NAFLD相关的HCC负担不断增加。某些因素,如种族、肥胖和糖尿病,似乎对NAFLD患者发生HCC的风险有累加作用。识别肝硬化的NAFLD患者存在困难,且非肝硬化的NAFLD患者也有可能发生HCC,这些都是需要解决的挑战。进一步了解这些差距可能有助于制定更好的监测策略,以便在NAFLD患者中早期发现HCC,从而降低死亡率并提高这些患者的生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05b/6206984/5e719cfc27f3/JGH3-2-235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05b/6206984/5e719cfc27f3/JGH3-2-235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05b/6206984/5e719cfc27f3/JGH3-2-235-g001.jpg

相似文献

1
Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.非酒精性脂肪性肝病相关肝细胞癌的流行病学及其影响
JGH Open. 2018 Jul 17;2(5):235-241. doi: 10.1002/jgh3.12070. eCollection 2018 Oct.
2
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.非酒精性脂肪性肝病所致肝细胞癌的流行趋势。
Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):179-187. doi: 10.1080/17474124.2019.1549989. Epub 2018 Dec 29.
3
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
4
Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link.非酒精性脂肪性肝病与肝细胞癌:一个有趣关联的临床挑战。
World J Gastroenterol. 2022 Jan 21;28(3):310-331. doi: 10.3748/wjg.v28.i3.310.
5
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌:日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
6
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
7
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
8
Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.20年间接受肝切除手术的非酒精性脂肪性肝病相关肝癌患者的时间趋势、临床模式及预后
Aliment Pharmacol Ther. 2017 Nov;46(9):856-863. doi: 10.1111/apt.14261. Epub 2017 Aug 31.
9
Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的肝细胞癌。
Curr Pharm Des. 2020;26(32):3909-3914. doi: 10.2174/1381612826666200429093648.
10
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌的流行病学
JHEP Rep. 2021 May 11;3(4):100305. doi: 10.1016/j.jhepr.2021.100305. eCollection 2021 Aug.

引用本文的文献

1
Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis.非肥胖型非酒精性脂肪性肝病与慢性肾脏病风险:一项系统评价与荟萃分析
PeerJ. 2024 Dec 17;12:e18459. doi: 10.7717/peerj.18459. eCollection 2024.
2
Use of Machine Learning to Predict Onset of NAFLD in an All-Comers Cohort-Development and Validation in 2 Large Asian Cohorts.利用机器学习预测普通人群队列中NAFLD的发病——在两个大型亚洲队列中的开发与验证
Gastro Hep Adv. 2024 Jun 21;3(7):1005-1011. doi: 10.1016/j.gastha.2024.06.007. eCollection 2024.
3
A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids.

本文引用的文献

1
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.2017年亚太地区非酒精性脂肪性肝病工作小组指南 - 第1部分:定义、危险因素及评估
J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857.
2
New trends on obesity and NAFLD in Asia.亚洲肥胖和非酒精性脂肪性肝病的新趋势。
J Hepatol. 2017 Oct;67(4):862-873. doi: 10.1016/j.jhep.2017.06.003. Epub 2017 Jun 19.
3
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
基于全基因组关联分析的 MLXIPL 基因变异与肝脂肪变性和血浆脂质的关系
Hepatol Commun. 2024 Apr 26;8(5). doi: 10.1097/HC9.0000000000000427. eCollection 2024 May 1.
4
A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease.HIV 和代谢功能障碍相关脂肪性肝病的肠道微生物组特征。
Front Immunol. 2023 Dec 14;14:1297378. doi: 10.3389/fimmu.2023.1297378. eCollection 2023.
5
Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling.脂联素通过 AMPK 信号通路调节脂质积累和炎症反应,从而促进非酒精性脂肪性肝病的发生。
Immun Inflamm Dis. 2023 Aug;11(8):e947. doi: 10.1002/iid3.947.
6
Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity.C 反应蛋白与严重肥胖个体非酒精性脂肪性肝病的组织学、弹性成像和超声指数的相关性。
J Health Popul Nutr. 2023 Apr 7;42(1):30. doi: 10.1186/s41043-023-00372-8.
7
Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.1990 - 2019年空腹血糖升高所致非酒精性脂肪性肝炎相关肝癌的全球疾病负担估计及趋势:基于2019年全球疾病负担研究数据的分析
Diabetol Metab Syndr. 2023 Jan 17;15(1):6. doi: 10.1186/s13098-022-00976-w.
8
lncRNA EPS15-AS1 affects the biological behavior of liver cancer stem cells by regulating EPS15 expression.长链非编码RNA EPS15-AS1通过调控EPS15的表达影响肝癌干细胞的生物学行为。
Am J Transl Res. 2022 Oct 15;14(10):7324-7335. eCollection 2022.
9
Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis.血管重构是肝肿瘤发生的啮齿动物模型肝癌发生早期的关键事件。
Cells. 2022 Jul 6;11(14):2129. doi: 10.3390/cells11142129.
10
Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges.非酒精性脂肪性肝病所致肝细胞癌:当前概念与未来挑战
J Hepatocell Carcinoma. 2022 Jun 1;9:477-496. doi: 10.2147/JHC.S344559. eCollection 2022.
糖尿病会增加肝细胞癌的风险,但丙型肝炎肝硬化患者除外。
Am J Gastroenterol. 2016 Nov;111(11):1573-1580. doi: 10.1038/ajg.2016.330. Epub 2016 Aug 16.
4
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
5
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.非酒精性脂肪性肝病相关肝细胞癌的临床特征:一项多中心前瞻性研究。
Hepatology. 2016 Mar;63(3):827-38. doi: 10.1002/hep.28368. Epub 2016 Jan 14.
6
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.非肝硬化非酒精性脂肪性肝病(NAFLD)患者肝细胞癌(HCC)的特征
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.
7
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.2004 年至 2009 年美国非酒精性脂肪性肝病(NAFLD)与肝细胞癌(HCC)的相关性。
Hepatology. 2015 Dec;62(6):1723-30. doi: 10.1002/hep.28123. Epub 2015 Oct 24.
8
Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.2001-2013 年美国退伍军人中潜在肝脏疾病导致的肝硬化和肝细胞癌负担趋势。
Gastroenterology. 2015 Nov;149(6):1471-1482.e5; quiz e17-8. doi: 10.1053/j.gastro.2015.07.056. Epub 2015 Aug 5.
9
Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.年轻多民族亚洲人群中的非酒精性脂肪性肝病:马来族和印度族男性令人担忧的种族偏好。
Hepatol Int. 2014 Jan;8(1):121-7. doi: 10.1007/s12072-013-9510-8. Epub 2014 Jan 3.
10
Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia.马来西亚一个多民族郊区亚洲人群中非酒精性脂肪性肝病的患病率及危险因素
Hepatol Int. 2013 Jun;7(2):548-54. doi: 10.1007/s12072-012-9359-2. Epub 2012 Mar 23.